IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2024-11-26 (fastighetsnytt.se)
The researcher fully leased
Vectura's life science building Forskaren in Hagastaden is fully let. It is clear after the company signed an agreement with IQVIA for the last 440 square meters.
Read more
2024-10-24 (monterrassa.cat)
MútuaTerrassa wins four IQVIA TOP20 Awards
The HUMT was distinguished for its Global Hospital Management, and in the areas of Digestive System, Pediatrics, Musculoskeletal
Read more
2024-07-16 (algerie-eco.com)
The Faculty of Pharmacy of Algiers signs a partnership agreement with Iqvia Algeria
A partnership agreement was signed on Tuesday in Algiers between the Faculty of Pharmacy of Algiers and “Iqvia Algeria”
Read more
2024-05-24 (financialexpress.com)
Biocon signs exclusive licensing deal for comercialisation of obesity drug in South Korea
The total addressable market opportunity of Liraglutide in Korea is approximately US $47 million as per the IQVIA MAT Q4 2023.
Read more
2024-05-13 (financialexpress.com)
Biocon signs deal with Medix for distribution and commercialisation of weight loss drug in Mexico
The total addressable market opportunity of Liraglutide for obesity indication in Mexico is approximately US $37 million as per the IQVIA MAT Q4 2023.
Read more
2024-05-13 (financialexpress.com)
Biocon signs deal with Medix for distribution and commercialisation of weight loss drug in Mexico
The total addressable market opportunity of Liraglutide for obesity indication in Mexico is approximately US $37 million as per the IQVIA MAT Q4 2023.
Read more
2023-11-13 (tmcnet.com)
Harvard Apparatus Regenerative Technology Reports Third Quarter 2023 Financial Results
Harvard Apparatus Regenerative Technology Reports Third Quarter 2023 Financial Results
Read more
2023-03-17 (thehindubusinessline.com)
stocks in action today
stock to watch today - TCS, Dr Reddy’s Lab, Eris Lifesciences, Glenmark Pharma, RVNL, Lemon Tree Hotels, IndiaMart InterMesh
Read more
2022-12-14 (financialexpress.com)
JB Pharma inks agreement with Glenmark to acquire statin franchise for Rs. 314 crores
Statins, also known as HMG-CoA reductase inhibitors, are a group of lipid-lowering drugs that reduce illness and mortality in those who are at high risk of cardiovascular disease.
Read more
2022-03-14 (globenewswire.com)
AVEO Oncology Reports Full Year and Fourth Quarter 2021 Financial Results
– Total 2021 Net Revenue of $42.3 Million – – FOTIVDA® (tivozanib) U.S. Net Product Revenue of $38.9 Million since March 22, 2021 – – FOTIVDA U.S. Net...
Read more
2021-04-09 (paho.org)
Market research to identify and analyze opportunities to produce strategic health technologies in Latin America and the Caribbean
Conducting market research and value chain analysis is crucial for defining a productive investment
Read more
2021-02-04 (wiadomoscikosmetyczne.pl)
The over 100-year-old pharmacy will definitely disappear from Sandomierz
The city of Sandomierz will soon announce a tender for the lease of premises in the former pharmacy at the Old Town Market Square - reports "Tygodnik Nadwiślański". At the same time, it informs that the residents are signing the appeal addressed to the city authorities to restore a pharmacy facility in this place.
Read more